A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis
Clinical trial NCT07749157 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07749157
- Sponsor
- Hoffmann-La Roche
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-23
- Primary completion
- 2031-02-28
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.